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Abstract 
The Nutrition and Health Claims Regulation (EC No. 1924/2006) has established a common 
framework for the regulation of nutrition and health claims used on foods across the European 
Union.  This regulation aims to provide the European food industry opportunities for product 
innovation whilst protecting consumer interests with respect to controlling misleading advertising 
and promoting public health. However, in order to satisfy the approval of new health claims 
procedure particularly for new ‘reduction of disease risk’ claims [Article 14(1)(a) claims] , significant 
research activity is required by industry to scientifically substantiate the claims they wish to make. 
There is a need to establish whether the implementation of this legislation is in fact driving product 
innovation and the development of healthy foods or whether it forms a barrier to such 
developments. The EU-funded REDICLAIM project is currently considering these issues. This article 
describes the project’s preliminary results and outlines the further programme of work.  
 
Introduction 
Differences in legislation related to providing health-related information have varied widely before 
the common European Union (EU) legislation on claims. This has acted not only as barrier against 
free movement of goods and fair competition, but has also as a potential barrier to investing in 
health-related research to produce products that have specific health outcomes, including those 
contributing to disease risk reduction. Reports of studies investigating labelling of pre-packaged 
foods in EU countries showed that while 7-14% of foods was labelled with health claims, reduction 
of disease risk’ claims were present on less than 1% of the investigated items (Hieke et al. 2016, 
Pravst et al. 2015). The European Regulation on nutrition and health claims on foods [Nutrition and 
Health Claims Regulation (hereafter NHCR) (European Commission (EC) No. 1924/2006; EC 2006, 
2008a,b,c, 2009a; European Parliament and the Council of the European Union 2007, 2008) is a 
harmonising law allowing health claims (Commission of the European Communities 2003) on foods 
to be made in a uniform manner throughout the Member States of the European Union (EU). Upon 
its introduction, the EC (2009b) stated that the main objectives of the proposed Regulation were to:  
• achieve a high level of consumer protection by providing further voluntary information, 
beyond the mandatory information foreseen by EU legislation;  
• improve the free movement of goods within the internal market; increase legal security for 
economic operators;  
• ensure fair competition in the area of foods; and  
• promote and protect innovation in the area of foods. 
The REDICLAIM (Understanding the impact of legislation on ‘REduction of DIsease risk’ CLAIMs on 
food and drinks) project aims to analyse whether these set goals have been achieved and whether 
they are regarded as achievable by stakeholders based on their opinions on how the legislation has 
been implemented.  
The NCHR (EC 2006) aims to safeguard that claims made on are substantiated by scientific evidence 
(EC 2008a,b,c, 2009b). The European Food Safety Authority (EFSA) is responsible for verifying the 
scientific substantiation of the claims submitted for authorisation in the EU. The EC then use EFSA's 
opinions to decide whether to authorise the claims. 
The REDICLAIM project focusses on new general function claims [Article 13(5)] which were not in use 
before 2006 or are based on newly developed scientific evidence, and ‘reduction of disease risk’ 
claims [Article 14(1)(a) claims] that state, suggest or imply that the consumption of a food or food 
constituent significantly reduces a risk factor in the development of a human disease. It should be 
noted that ‘Reduction of disease risk’ claims are different from medicinal claims that relate to the 
prevention a disease. For both new general function claims and reduction of disease risk claims, 
applicants can request for 5 years of protection of proprietary data. This gives companies time to 
differentiate their products from those of other companies and is thus create a competitive 
advantage through product innovation.  
Food products with health claims, particularly ‘reduction of disease risk’ claims require 
multidisciplinary research efforts from identifying the potential risk factors through to applying the 
gained knowledge in concrete food applications. An increased prevalence of life style-related non-
communicable diseases has fuelled the interest in the associations between food and health, 
resulting not only in higher public funding of multidisciplinary science projects, but also higher 
private investment. 
REDICLAIM is an EU-funded project which started in 2013 and ends in October 2016. The project 
seeks to assess the NCHR (2006). REDICLAIM will: (1) Seek to understand the (a) main issues and 
hurdles concerning substantiation and use of ‘reduction of disease risk’ claims on food and drinks; 
(b) level of awareness about legal obligations with regard to ‘reduction of disease risk’ claims on 
food and drinks among the relevant stakeholders; and (2) Produce a three-fold study of the impact 
of nutrition and health claims legislation specific to ‘reduction of disease risk’ claims on food and 
drinks on: (a) The claim substantiation process, (b) Health research and/or innovation in the food 
chain, and (c) Nutrition economic models to determine health impact. An overview of the project 
structure and research plans can be found in Raats et al. (2015). 
 
Results and discussion 
Work package 1: Stakeholder engagement and dissemination 
REDICLAIM's community of interested stakeholders (e.g. industry, regulatory bodies, clinical trial 
specialists, scientists, health professionals and civil society) is being brought together to reflect on 
project findings. 
 
Work package 2: Establish the regulatory frameworks for ‘reduction of disease risk’ claims on food 
and drinks 
A desk-based exercise coupled with interviews at government level, mapped the regulatory 
framework and decision-making process for health and nutrition claims at EU level; and mapped and 
analysed the implementation of the regulatory framework for ‘reduction of disease risk’ claims at 
Member State level. It is clear that there are significant problems relating to the operation of the 
Nutrition and Health Clams Regulation (EC) No 1924/2006 (hereafter NHCR). These arise from a 
variety of factors including: 
• the clash between the twin aims of consumer protection and trade; 
• the inevitable centring of the NHCR on Article 114 of the Treaty for the Functioning of the 
European Union; 
• the lack of a clear legal basis in the Treaty for the Functioning of the European Unionfor 
public health and nutrition matters; 
• the uneasy fit of NHCR into the food safety context when it is in fact based on the medicines 
evaluation model whereby proof of efficacy rests upon the link between active ingredient 
and health and the health outcome which is likely to be achieved; 
• the role of EFSA in the evaluation of claims under the NHCR where EFSA’s primary function is 
in assessing risk rather than in the evaluation and analysis of the benefit of an ingredient; 
• the lack of a clear mandate and basis for EFSA to act in NHCR claims;  
• the lengthy delays in processing claims; and 
• legal aspects of the regulation, particularly the ‘comitology’ procedures which pertained at 
the time of implementation of NHCR.  
A second task mapped the top-level implementation of ‘reduction of disease risk’ claims at Member 
State level. The purpose was to identify and illustrate the role of the Member States in the 
authorisation and enforcement process, as well as potential differences between the approaches of 
each Member State regarding the use of ‘reduction of disease risk’ claims on food. In most cases the 
national framework was concerned with the implementation of Directive 2000/13 EC (now replaced 
by Regulation 1169/2011) on food labelling. All member states had national legislation 
supplementing NHCR but in varying degrees. 
 
Work package 3: Exploring the interaction between legislation and health research and/or 
innovation in the food chain  
Health claim substantiations are performed by taking the totality of the available pertinent scientific 
data into account and by weighing it, in particular as to whether: (1) the effect is relevant for human 
health; (2) there is an established cause and effect relationship between the consumption of the 
food and the claimed effect in humans; (3) the effect has been shown on a study group which is 
representative of the target population; and (4) the quantity of the food and pattern of consumption 
required to obtain the claimed effect could reasonably be achieved as part of a balanced diet. 
The first task identified the kind of research used to support health claim applications based on new 
knowledge (13.5 claims) and ‘reduction of disease risk’ claims (14.1a claims). Claim substantiation is 
mainly based on relatively new but not the most recent peer-reviewed and published research. 
Companies have a role in partly funding the research in co-operating with the academic researchers, 
but the use of unpublished data is limited in claim applications. EU’s role as a funding body is very 
limited in the cardiovascular health claim applications submitted by the end of 2013. Further work 
will explore food manufacturers' willingness/capability to exploit new research findings in cardio-
vascular health related innovation processes; and the role of health claim regulation as a facilitator 
or barrier to research-based innovation aimed at developing products based on new findings and 
risk reduction of diseases. 
 
Work package 4: Ascertaining the interaction between legislation and the claim substantiation 
process 
The first task compared NHCR with health claims legislation in other developed countries (USA, 
Canada, Australia, New Zealand), focusing on advantages and disadvantages of different solutions 
from a research and development perspective. In all selected jurisdictions, ‘reduction of disease risk’ 
claims need to be pre-approved before being used on the market. Food businesses have the 
possibility to apply for authorization of new ‘reduction of disease risk’ claims and procedures are 
well defined. Applicants are fully responsible for preparation of application dossiers. The process of 
evaluation of the submitted proposals and authorization of new health claims is not subject to fees, 
however it is likely that fees will be implemented in Australia and New Zealand. Typical description 
of the strength of scientific evidence needed for approval of such health claims is ‘generally 
accepted scientific evidence of beneficial physiological effect in humans’ in the EU, ‘significant 
scientific agreement’ in the USA and Canada, and ‘established food-health relationship based on the 
totality and weight of evidence’ in Australia and New Zealand. Further work will include an 
investigation of known assessments of health claim applications and reasons for rejections; and case 
studies on applicants’ experiences of the health claim application process with focus on positively 
and negatively assessed applications. 
 
Work package 5: Nutrition economic models for food constituents associated with 'reduction of 
disease risk' claims 
Based on a review of the relevant literature, a decision analytic model has been built and parameters 
have been assembled to appraise the cost-effectiveness of plant sterol/stanols in the management 
of people with hypercholesterolemia.  Based on the English population, the model is being used to 
calculate cardio vascular disease risk reduction associated with plant sterols/stanols incorporated in 
dairy products/margarine spreads, when compared to a normal diet. The number of avoided events, 
and the associated savings to the British National Health Service, are being simulated over 20 years 
under varying assumptions about compliance rates.  This will show whether promotion of sterol/ 
stanol enriched functional foods are cost effective, and for which age and sex groups in the 
population. 
 
Conclusions 
One of the central aims of the NCHR is to ensure a high level of consumer protection through 
requiring that all health claims be scientifically substantiated and approved before use; thus creating 
a positive list of claims for use in the European market. REDICLAIM results will contribute to the: 
• Development of an evidence base of the process by which health claims are made and 
controlled by regulatory frameworks. 
• Effectiveness of the control of health claims by regulation. 
• Establishment of recommendations for government, industry and the scientific community 
with a view to conducting the necessary research and development of products carrying 
health claims. 
In order to achieve both effective compliance with better regulation and, to contribute to the 
enhancement of innovative and competitive products REDICLAIM will: 
• Enable the identification of regulation as a barrier or driver to the use of ‘reduction of 
disease risk’ claims and their scientific basis. 
• Identify regulatory gaps and will develop guidelines for the effective regulation of health 
claims which enable and enhance innovation while meeting the consumer and ethical 
perspectives. Support tools will be developed for stakeholders to inform issues concerning 
the substantiation and use of ‘reduction of disease risk’ claims on food and drinks. 
• Provide the European legislator with a proposal for issues relating to the enforcement of 
legislation specific to substantiation and use of ‘reduction of disease risk’ claims on food and 
drinks. 
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